Cilastatin effectively reduces the incidence of acute ciclosporin-induced nephrotoxicity among transplant recipients

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1151, 2007-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ciclosporin: Leukoencephalopathy in transplant recipients: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1104, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Ciclosporin decrease improves renal function in transplant recipients

Inpharma, Vol. 1, Iss. 1464, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Octreotide effectively reduces the incidence of post-ERCP pancreatitis

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Blood and Plasma Pharmacokinetics of Ciclosporin in Diabetic Kidney Transplant Recipients

By Mendonza Anisha E.

Clinical Pharmacokinetics, Vol. 47, Iss. 11, 2008-01 ,pp. : 733-742

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Ciclosporin Withdrawal in Renal Transplant Recipients

By Thervet E. Martinez F. Legendre C.

Drug Safety, Vol. 27, Iss. 7, 2004-01 ,pp. : 457-476

Adis International

Access to resources Recommend Favorite